PSP
MCID: PRG006
MIFTS: 70

Progressive Supranuclear Palsy (PSP) malady

Neuronal diseases, Eye diseases, Genetic diseases categories

Summaries for Progressive Supranuclear Palsy

About this section
Sources:
21Genetics Home Reference, 42NIH Rare Diseases, 33MedlinePlus, 43NINDS, 63Wikipedia, 46OMIM, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
MedlinePlus:33 Progressive supranuclear palsy (psp) is a rare brain disease. it affects brain cells that control the movement of your eyes. this leads to serious and permanent problems with balance and the way you walk. it usually occurs in middle-aged or elderly people. symptoms are very different in each person, but may include personality changes, speech, vision and swallowing problems. doctors sometimes confuse psp with parkinson's disease or alzheimer's disease. psp has no cure and no effective treatments. walking aids, special glasses and certain medicines might help somewhat. although the disease gets worse over time, it isn't fatal on its own. however, psp is dangerous because it increases your risk of pneumonia and choking from swallowing problems and injuries from falling. nih: national institute of neurological disorders and stroke

MalaCards: Progressive Supranuclear Palsy, also known as supranuclear palsy, progressive, is related to parkinson's disease and multiple system atrophy. An important gene associated with Progressive Supranuclear Palsy is MAPT (microtubule-associated protein tau), and among its related pathways is Muscarinic acetylcholine receptors. The compounds mt2 and mt1 have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and cortex, and related mouse phenotypes are normal and nervous system.

Genetics Home Reference:21 Progressive supranuclear palsy is a brain disorder that affects movement, vision, speech, and thinking ability (cognition). The signs and symptoms of this disorder usually become apparent in mid- to late adulthood, most often in a person's 60s. Most people with progressive supranuclear palsy survive 5 to 9 years after the disease first appears, although a few affected individuals have lived for more than a decade.

NIH Rare Diseases:42 Progressive supranuclear palsy is a movement disorder caused by damage to certain nerve cells in the brain. it affects brain cells that control the movement of the eyes. this leads to serious and permanent problems with balance and the way affected individuals walk. it usually occurs in middle-aged or elderly people. symptoms are very different in each person, but may include personality changes, speech, vision and swallowing problems. doctors sometimes confuse progressive supranuclear palsy with parkinson's disease or alzheimer's disease. progressive supranuclear palsy has no cure and no effective treatments. in most cases, the genetic cause of this condition is unknown. rarely, the disease results from mutations in the mapt gene.  last updated: 8/18/2011

NINDS:43 Progressive supranuclear palsy (PSP) is a rare brain disorder that causes serious and progressive problems with control of gait and balance, along with complex eye movement and thinking problems. One of the classic signs of the disease is an inability to aim the eyes properly, which occurs because of lesions in the area of the brain that coordinates eye movements. Some individuals describe this effect as a blurring. Affected individuals

Wikipedia:63 Progressive supranuclear palsy (PSP) (or the Steele-Richardson-Olszewski syndrome, after the Canadian... more...

Description from OMIM:46 601104,609454,610898

Aliases & Classifications for Progressive Supranuclear Palsy

About this section
Sources:
8Disease Ontology, 42NIH Rare Diseases, 21Genetics Home Reference, 43NINDS, 10DISEASES, 33MedlinePlus, 60UMLS, 22GTR, 9diseasecard, 46OMIM, 44Novoseek, 48Orphanet, 56SNOMED-CT, 39NCIt, 34MeSH, 26ICD10 via Orphanet, 25ICD10
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases
Anatomical: Neuronal diseases, Eye diseases


Characteristics (Orphanet epidemiological data):

48
classical progressive supranuclear palsy:
Inheritance: Sporadic; Prevalence: 1-9/100000; Age of onset: Adulthood; Age of death: Elderly


Aliases & Descriptions:

progressive supranuclear palsy 8 42 21 43 10 33 60
supranuclear palsy, progressive 9 42 21 46
progressive supranuclear ophthalmoplegia 8 22 21
steele-richardson-olszewski syndrome 42 21 43
familial progressive supranuclear palsy 42 60
psp 42 21
classical progressive supranuclear palsy 48
steele-richardson-olszewski disease 48
supranuclear palsy progressive 44
richardson's syndrome 21
richardson syndrome 48
classical psp 48


External Ids:

Disease Ontology8 DOID:678
NCIt39 C85028
MeSH34 D013494
ICD10 via Orphanet26 G23.1
ICD1025 G23.1

Related Diseases for Progressive Supranuclear Palsy

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Progressive Supranuclear Palsy family:

Progressive Supranuclear Palsy, Mapt-Related Supranuclear Palsy, Progressive, 2
Supranuclear Palsy, Progressive, 3

Diseases related to Progressive Supranuclear Palsy via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 95)
idRelated DiseaseScoreTop Affiliating Genes
1parkinson's disease31.6RPS27A, MAPT
2multiple system atrophy31.5RPS27A, PVALB, MAPT
3dementia31.3RPS27A, PVALB, STH, CHRM1, MAPT, HCRT
4alzheimer's disease31.1RPS27A, PVALB, STH, NEFL, CHRM1, MAPT
5frontotemporal dementia31.1MAPT, STH, RPS27A
6pick's disease31.0MAPT, RPS27A
7tauopathy30.9RPS27A, STH, MAPT
8amyotrophic lateral sclerosis30.6RPS27A, PVALB, NEFL, MAPT
9normal pressure hydrocephalus30.5HCRT, MAPT
10motor neuron disease30.5RPS27A, PVALB, MAPT
11niemann-pick disease30.2MAPT, HCRT
12cerebritis10.7
13neuronitis10.7
14cerebral palsy10.7
15apraxia10.7
16brain disease10.7
17aphasia10.6
18lateral sclerosis10.6
19striatonigral degeneration10.6
20ophthalmoplegia10.6
21progressive supranuclear palsy atypical10.5
22internuclear ophthalmoplegia10.5
23basal ganglia disease10.5
24cerebral degeneration10.5
25sleep disorder10.5
26feigenbaum bergeron richardson syndrome10.4
27rem sleep behavior disorder10.4
28cerebellar ataxia10.4
29cerebellar disease10.4
30cervicitis10.4
31hypertension10.4
32progressive supranuclear palsy - progressive non fluent aphasia10.4
33lewy body dementia10.3
34hydrocephalus10.3
35movement disease10.3
36progressive supranuclear palsy, mapt-related10.3
37supranuclear palsy, progressive, 210.3
38supranuclear palsy, progressive, 310.3
39progressive supranuclear palsy - corticobasal syndrome10.3
40progressive supranuclear palsy - pure akinesia with gait freezing10.3
41leopard syndrome10.2
42atherosclerosis - deafness - diabetes - epilepsy - nephropathy10.2
43wrinkles10.2
44corneal disease10.2
45postencephalitic parkinson disease10.2
46subclavian steal syndrome10.2
47antiphospholipid syndrome10.2
48major depressive disorder10.2
49essential tremor10.2
50hypoparathyroidism10.2

Graphical network of the top 20 diseases related to Progressive Supranuclear Palsy:



Diseases related to progressive supranuclear palsy

Clinical Features for Progressive Supranuclear Palsy

About this section
Sources:
46OMIM
See all sources

Clinical features from OMIM:

601104,609454,610898

Clinical synopsis from OMIM:

601104

Drugs & Therapeutics for Progressive Supranuclear Palsy

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Progressive Supranuclear Palsy

Drug clinical trials:

Search ClinicalTrials for Progressive Supranuclear Palsy

Search NIH Clinical Center for Progressive Supranuclear Palsy

Search CenterWatch for Progressive Supranuclear Palsy

Genetic Tests for Progressive Supranuclear Palsy

About this section
Sources:
22GTR
See all sources

Genetic tests related to Progressive Supranuclear Palsy:

id Genetic test Affiliating Genes
1 Progressive Supranuclear Ophthalmoplegia22

Anatomical Context for Progressive Supranuclear Palsy

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Progressive Supranuclear Palsy:

32
Brain, Eye, Cortex, Thalamus, Spinal cord, Pons, Cerebellum, Globus pallidus, Subthalamic nucleus, B cells, Testes, Colon, Skeletal muscle, Medulla oblongata

Animal Models for Progressive Supranuclear Palsy or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Progressive Supranuclear Palsy:

36
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000287310.2NEFL, VEGFA, MAPT, HIST1H1E, WNT3, IL21
2MP:00036319.9ACP2, PVALB, NEFL, CHRM4, CHRM1, VEGFA

Publications for Progressive Supranuclear Palsy

About this section
Sources:
50PubMed
See all sources

Articles related to Progressive Supranuclear Palsy:

(show top 50)    (show all 653)
idTitleAuthorsYear
1
Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy. (24413640)
2014
2
Acute colonic pseudo-obstruction (Ogilvie syndrome) in progressive supranuclear palsy. (22902091)
2013
3
Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy. (23477861)
2013
4
DCTN1 Mutation Analysis in Families With Progressive Supranuclear Palsy-Like Phenotypes. (24343258)
2013
5
Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy. (23670309)
2013
6
Combined rehabilitation program for postural instability in progressive supranuclear palsy. (23867411)
2013
7
Deep magnetic stimulation in a progressive supranuclear palsy patient with speech involvement. (23212758)
2013
8
Clinical pain and experimental pain sensitivity in progressive supranuclear palsy. (22130148)
2012
9
Successful airway management of a patient with progressive supranuclear palsy during the induction of anesthesia. (22769866)
2012
10
Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. (22488922)
2012
11
MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. (21469210)
2011
12
Cost-of-illness in multiple system atrophy and progressive supranuclear palsy. (21479850)
2011
13
Movement disorders: Imaging differentiates progressive supranuclear palsy from Parkinson disease. (21468117)
2011
14
Dual pathology of corticobasal degeneration and Parkinson's disease in a patient with clinical features of progressive supranuclear palsy. (22234205)
2011
15
Characteristic constant groaning in late stage progressive supranuclear palsy: a case report. (21571571)
2011
16
Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. (20569300)
2010
17
VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome. (20413880)
2010
18
Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study. (19412943)
2009
19
Welcome to the club: substantial sleep dysfunction also in progressive supranuclear palsy. (19109064)
2009
20
Repetitive transcranial magnetic stimulation in patients with progressive supranuclear palsy: a pilot study. (19902813)
2009
21
Parkinsonism, dysautonomia, REM behaviour disorder and visual hallucinations mimicking synucleinopathy in a patient with progressive supranuclear palsy. (19372296)
2009
22
Progressive supranuclear palsy-like syndrome induced by amiodarone and flunarizine. (19838530)
2009
23
Familial neurodegeneration in progressive supranuclear palsy: more frequent than expected? (19420350)
2009
24
Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. (18688134)
2008
25
Genetics of progressive supranuclear palsy. (18631770)
2008
26
Signal changes of superior cerebellar peduncle on fluid-attenuated inversion recovery in progressive supranuclear palsy. (17481936)
2008
27
Clinical aspects of progressive supranuclear palsy. (18631769)
2008
28
Co-occurrence of radiological features of progressive supranuclear palsy and corticobasal degeneration. (17272907)
2007
29
Progressive supranuclear palsy. (18808956)
2007
30
Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy. (17274033)
2007
31
Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. (17357082)
2007
32
Diagnostic potential of saccadometry in progressive supranuclear palsy. (20477368)
2007
33
Effect of gabapentin on oculomotor control and parkinsonism in patients with progressive supranuclear palsy. (17718702)
2007
34
Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. (15843423)
2005
35
New and reliable MRI diagnosis for progressive supranuclear palsy. (15985570)
2005
36
Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy. (15235807)
2004
37
Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy. (14969740)
2004
38
Levodopa-induced oromandibular dystonia in progressive supranuclear palsy. (12691807)
2003
39
Procerus sign in progressive supranuclear palsy and corticobasal degeneration. (12521196)
2002
40
Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. (11935262)
2002
41
Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. (10718204)
2000
42
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. (10716259)
2000
43
Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease. (10896267)
2000
44
Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. (11089576)
2000
45
Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. (10517506)
1999
46
Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. (9562324)
1998
47
Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls. (9380049)
1997
48
Morphologic difference of neuropil threads in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy: a morphometric study. (9350839)
1997
49
Corticobasal degeneration: widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy. (8791241)
1996
50
Neurofibrillary tangles in the neurons of spinal dorsal root ganglia of patients with progressive supranuclear palsy. (8388145)
1993

Genetic Variations for Progressive Supranuclear Palsy

About this section
Sources:
62UniProtKB/Swiss-Prot
See all sources

Genetic disease variations for Progressive Supranuclear Palsy:

62
id Symbol AA change Variation ID SNP ID
1MAPTp.Arg5LeuVAR_019661rs63750959
2MAPTp.Gly620ValVAR_037439

Expression for genes affiliated with Progressive Supranuclear Palsy

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Progressive Supranuclear Palsy

Search GEO for disease gene expression data for Progressive Supranuclear Palsy.

Pathways for genes affiliated with Progressive Supranuclear Palsy

About this section
Sources:
53Reactome
See all sources

Pathways related to Progressive Supranuclear Palsy according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.4CHRM1, CHRM4

Compounds for genes affiliated with Progressive Supranuclear Palsy

About this section
Sources:
28IUPHAR, 11DrugBank, 44Novoseek, 59Tocris Bioscience, 49PharmGKB, 24HMDB
See all sources

Compounds related to Progressive Supranuclear Palsy according to GeneCards/GeneDecks:

(show top 50)    (show all 78)
idCompoundScoreTop Affiliating Genes
1mt22810.9CHRM4, CHRM1
2mt12810.9CHRM4, CHRM1
3eburnamonine2810.8CHRM1, CHRM4
4oxotremorine-m2810.8CHRM1, CHRM4
5mcn-a-3432810.8CHRM4, CHRM1
6win 51,7082810.8CHRM4, CHRM1
7vincamine2810.8CHRM4, CHRM1
8arecaidine propargyl ester2810.8CHRM4, CHRM1
9thiochrome2810.8CHRM4, CHRM1
10alcuronium2810.8CHRM4, CHRM1
11milameline2810.8CHRM1, CHRM4
12gö 78742810.8CHRM1, CHRM4
13Hyoscyamine1110.8CHRM4, CHRM1
14Procyclidine1110.8CHRM4, CHRM1
15tropicamide44 59 1112.8CHRM4, CHRM1
16nmda44 2811.8RPS27A, PVALB, MAPT, HCRT
17furmethide2810.8CHRM4, CHRM1
18methylfurmethide2810.8CHRM4, CHRM1
19carbachol44 28 1112.8MAPT, CHRM1, CHRM4, HCRT
20win 62,5772810.8CHRM4, CHRM1
21sabcomeline2810.8CHRM4, CHRM1
22pentylthio-tztp2810.8CHRM4, CHRM1
23propantheline28 1111.8CHRM1, CHRM4
24brucine n-oxide2810.8CHRM4, CHRM1
25[3h]n-methyl scopolamine2810.8CHRM1, CHRM4
26n-chloromethyl-brucine2810.8CHRM4, CHRM1
27n-benzyl brucine2810.8CHRM4, CHRM1
28[3h]qnb2810.8CHRM4, CHRM1
29thioflavine s4410.7MAPT, RPS27A
304-damp59 2811.7CHRM4, CHRM1
31Metixene1110.7CHRM4, CHRM1
32acetylcholine44 49 28 11 2414.7CHRM1, RPS27A, PVALB, HCRT, MAPT, CHRM4
33Trihexyphenidyl1110.7CHRM4, CHRM1
34Cryptenamine1110.7CHRM4, CHRM1
35Homatropine Methylbromide1110.7CHRM4, CHRM1
36(+)aceclidine2810.7CHRM1, CHRM4
37ipratropium2810.7CHRM1, CHRM4
38nnc 11-13142810.7CHRM4, CHRM1
39(-)aceclidine2810.7CHRM4, CHRM1
40afdx3842810.6CHRM1, CHRM4
41mt32810.6CHRM1, CHRM4
42af-dx 11628 5911.6CHRM1, CHRM4
43vu02550352810.6CHRM1, CHRM4
44p-f-hhsid2810.6CHRM4, CHRM1
45nnc 11-15852810.5CHRM1, CHRM4
46mt72810.5CHRM4, CHRM1
47nnc 11-16072810.4CHRM1, CHRM4
48arecoline44 28 1112.4CHRM4, CHRM1
49hhsid2810.3CHRM1, CHRM4
50himbacine28 4411.1CHRM1, CHRM4

GO Terms for genes affiliated with Progressive Supranuclear Palsy

About this section
Sources:
16Gene Ontology
See all sources

Biological processes related to Progressive Supranuclear Palsy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1G-protein coupled acetylcholine receptor signaling pathwayGO:00721310.4CHRM1, CHRM4
2regulation of locomotionGO:04001210.1CHRM1, CHRM4

Molecular functions related to Progressive Supranuclear Palsy according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1receptor agonist activityGO:04801810.4WNT3, VEGFA
2G-protein coupled acetylcholine receptor activityGO:01690710.1CHRM1, CHRM4

Products for genes affiliated with Progressive Supranuclear Palsy

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Progressive Supranuclear Palsy

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet